rs371931644

Variant summary

Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_000719.7(CACNA1C):​c.5277G>A​(p.Ser1759Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000235 in 1,613,862 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.000033 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000023 ( 0 hom. )

Consequence

CACNA1C
NM_000719.7 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.40
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C-AS1 (HGNC:40119): (CACNA1C antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 12-2679629-G-A is Benign according to our data. Variant chr12-2679629-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 416877.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-2679629-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-1.4 with no splicing effect.
BS2
High AC in GnomAd4 at 5 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CACNA1CNM_000719.7 linkc.5277G>A p.Ser1759Ser synonymous_variant 42/47 ENST00000399655.6 NP_000710.5 Q13936-12
CACNA1CNM_001167623.2 linkc.5277G>A p.Ser1759Ser synonymous_variant 42/47 ENST00000399603.6 NP_001161095.1 Q13936-37

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.5277G>A p.Ser1759Ser synonymous_variant 42/475 NM_001167623.2 ENSP00000382512.1 Q13936-37
CACNA1CENST00000399655.6 linkc.5277G>A p.Ser1759Ser synonymous_variant 42/471 NM_000719.7 ENSP00000382563.1 Q13936-12
CACNA1CENST00000682544.1 linkc.5511G>A p.Ser1837Ser synonymous_variant 44/50 ENSP00000507184.1 A0A804HIR0
CACNA1CENST00000406454.8 linkc.5277G>A p.Ser1759Ser synonymous_variant 42/485 ENSP00000385896.3 F5GY28
CACNA1CENST00000399634.6 linkc.5244G>A p.Ser1748Ser synonymous_variant 41/475 ENSP00000382542.2 E9PDI6
CACNA1CENST00000683824.1 linkc.5442G>A p.Ser1814Ser synonymous_variant 43/48 ENSP00000507867.1 A0A804HKC4
CACNA1CENST00000347598.9 linkc.5421G>A p.Ser1807Ser synonymous_variant 44/491 ENSP00000266376.6 Q13936-11
CACNA1CENST00000344100.7 linkc.5400G>A p.Ser1800Ser synonymous_variant 42/471 ENSP00000341092.3 Q13936-14
CACNA1CENST00000327702.12 linkc.5277G>A p.Ser1759Ser synonymous_variant 42/481 ENSP00000329877.7 A0A0A0MR67
CACNA1CENST00000399617.6 linkc.5277G>A p.Ser1759Ser synonymous_variant 42/485 ENSP00000382526.1 A0A0A0MSA1
CACNA1CENST00000682462.1 linkc.5367G>A p.Ser1789Ser synonymous_variant 42/47 ENSP00000507105.1 A0A804HIJ8
CACNA1CENST00000683781.1 linkc.5367G>A p.Ser1789Ser synonymous_variant 42/47 ENSP00000507434.1 A0A804HJB6
CACNA1CENST00000683840.1 linkc.5367G>A p.Ser1789Ser synonymous_variant 42/47 ENSP00000507612.1 A0A804HJR1
CACNA1CENST00000683956.1 linkc.5367G>A p.Ser1789Ser synonymous_variant 42/47 ENSP00000506882.1 A0A804HI37
CACNA1CENST00000399638.5 linkc.5361G>A p.Ser1787Ser synonymous_variant 43/481 ENSP00000382547.1 Q13936-31
CACNA1CENST00000335762.10 linkc.5352G>A p.Ser1784Ser synonymous_variant 43/485 ENSP00000336982.5 F5H522
CACNA1CENST00000399606.5 linkc.5337G>A p.Ser1779Ser synonymous_variant 43/481 ENSP00000382515.1 Q13936-30
CACNA1CENST00000399621.5 linkc.5334G>A p.Ser1778Ser synonymous_variant 42/471 ENSP00000382530.1 Q13936-24
CACNA1CENST00000399637.5 linkc.5334G>A p.Ser1778Ser synonymous_variant 42/471 ENSP00000382546.1 Q13936-27
CACNA1CENST00000402845.7 linkc.5334G>A p.Ser1778Ser synonymous_variant 42/471 ENSP00000385724.3 Q13936-13
CACNA1CENST00000399629.5 linkc.5328G>A p.Ser1776Ser synonymous_variant 42/471 ENSP00000382537.1 Q13936-32
CACNA1CENST00000682336.1 linkc.5319G>A p.Ser1773Ser synonymous_variant 42/47 ENSP00000507898.1 A0A804HKE9
CACNA1CENST00000399591.5 linkc.5301G>A p.Ser1767Ser synonymous_variant 41/461 ENSP00000382500.1 Q13936-29
CACNA1CENST00000399595.5 linkc.5301G>A p.Ser1767Ser synonymous_variant 41/461 ENSP00000382504.1 Q13936-25
CACNA1CENST00000399649.5 linkc.5295G>A p.Ser1765Ser synonymous_variant 41/461 ENSP00000382557.1 Q13936-15
CACNA1CENST00000399597.5 linkc.5277G>A p.Ser1759Ser synonymous_variant 42/471 ENSP00000382506.1 Q13936-22
CACNA1CENST00000399601.5 linkc.5277G>A p.Ser1759Ser synonymous_variant 42/471 ENSP00000382510.1 Q13936-20
CACNA1CENST00000399641.6 linkc.5277G>A p.Ser1759Ser synonymous_variant 42/471 ENSP00000382549.1 Q13936-23
CACNA1CENST00000399644.5 linkc.5277G>A p.Ser1759Ser synonymous_variant 42/471 ENSP00000382552.1 Q13936-21
CACNA1CENST00000682835.1 linkc.5277G>A p.Ser1759Ser synonymous_variant 42/47 ENSP00000507282.1 A0A804HIZ0
CACNA1CENST00000683482.1 linkc.5268G>A p.Ser1756Ser synonymous_variant 42/47 ENSP00000507169.1 Q13936-35
CACNA1CENST00000682686.1 linkc.5244G>A p.Ser1748Ser synonymous_variant 41/46 ENSP00000507309.1 Q13936-19

Frequencies

GnomAD3 genomes
AF:
0.0000329
AC:
5
AN:
152168
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.0000283
AC:
7
AN:
247394
Hom.:
0
AF XY:
0.0000223
AC XY:
3
AN XY:
134398
show subpopulations
Gnomad AFR exome
AF:
0.000130
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000898
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000226
AC:
33
AN:
1461576
Hom.:
0
Cov.:
31
AF XY:
0.0000179
AC XY:
13
AN XY:
727082
show subpopulations
Gnomad4 AFR exome
AF:
0.000119
Gnomad4 AMR exome
AF:
0.0000671
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000162
Gnomad4 OTH exome
AF:
0.0000994
GnomAD4 genome
AF:
0.0000328
AC:
5
AN:
152286
Hom.:
0
Cov.:
33
AF XY:
0.0000134
AC XY:
1
AN XY:
74446
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.0000434
Hom.:
0
Bravo
AF:
0.0000529
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

CACNA1C-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesSep 17, 2024This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Timothy syndrome;C2678478:Brugada syndrome 3;CN260585:Long qt syndrome 8 Benign:1
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsJul 28, 2021- -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015- -
Long QT syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJul 14, 2023- -
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsDec 21, 2023This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.57
CADD
Benign
2.1
DANN
Benign
0.88

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs371931644; hg19: chr12-2788795; COSMIC: COSV59694900; COSMIC: COSV59694900; API